Spherix Incorporated News Today

FOXO Technologies (NYSE:FOXO – Get Free Report) and AIkido Pharma (NASDAQ:AIKI – Get Free Report) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, earnings, dividends and profitability. Volatility & Risk FOXO Technologies has […]

FOXO Technologies (NYSE:FOXO – Get Free Report) and AIkido Pharma (NASDAQ:AIKI – Get Free Report) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability and valuation. Risk and Volatility FOXO Technologies has […]

FOXO Technologies (NYSE:FOXO – Get Free Report) and AIkido Pharma (NASDAQ:AIKI – Get Free Report) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings and valuation. Risk & Volatility FOXO Technologies has […]

AIkido Pharma (NASDAQ:AIKI – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Friday, Zacks.com reports. According to Zacks, “AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics. The company’s pipeline of therapeutics […]

Investment Analysts’ updated eps estimates for Friday, June 10th: American Assets Trust (NYSE:AAT) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “American Assets, Inc. is a real estate investment trust, or REIT, that owns, operates, acquires and develops retail and office properties primarily in […]

AIkido Pharma (NASDAQ:AIKI – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Thursday, Zacks.com reports. According to Zacks, “AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics. The company’s pipeline of therapeutics […]

AIkido Pharma (NASDAQ:AIKI – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Monday, Zacks.com reports. According to Zacks, “AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics. The company’s pipeline of therapeutics includes […]

Cardiometabolic disease, commonly known as Reaven’s syndrome, is characterized by a group of abnormalities and symptoms that include abdominal obesity, high-blood pressure, poor cholesterol profile, dyslipidemia, and high plasma glucose.